Comparative efficacy of 5 sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor and 4 glucagon-like peptide-1 (GLP-1) receptor agonist drugs in non-alcoholic fatty liver disease: A GRADE-assessed systematic review and network meta-analysis of randomized controlled trials

• Main Authors: Yunpeng Gu (Author), Lei Sun (Author), Wei Zhang (Author), Tingting Kong (Author), Run Zhou (Author), Yining He (Author), Chaohua Deng (Author), Luping Yang (Author), Jianing Kong (Author), Yutong Chen (Author), Junping Shi (Author), Yanli Hu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The relative efficacy of 5 sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and 4 glucagon-like peptide-1 (GLP-1) receptor agonists for non-alcoholic fatty liver disease (NAFLD) therapy has not been sufficiently investigated.Methods: Randomized controlled trials (RCTs) in which...